Capital Investment Advisors LLC Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Capital Investment Advisors LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,350 shares of the financial services provider’s stock after selling 472 shares during the quarter. Capital Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,507,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at approximately $27,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $31,000. Mather Group LLC. bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at approximately $57,000. Chris Bulman Inc bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $64,000. Finally, BNP Paribas bought a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at approximately $69,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.2 %

NASDAQ IBB opened at $145.91 on Monday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.57. The stock has a 50 day moving average price of $145.65 and a 200-day moving average price of $139.69.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.